By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

A Chinese surgeon remotely operated a robotic system to remove a prostate tumor from a patient 220 kilometers away. Utilizing ...

Here is how robotic surgeries are paving way for new gen cancer treatment in the country - Read on to know all about it.

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...

Compared with patients receiving hormone therapy alone, patients were nine times more likely to have little to no cancer remaining in the prostate after surgery, with a 20 percent reduction in the ris ...

The Society of Interventional Radiology (SIR) has published new practice guidance for the use of prostatic artery ...

Johnson & Johnson said its prostate cancer drug Erleada, when used with hormone-blocking therapy before and after prostate ...

Are you a man whose bathroom breaks make it hard to sleep through the night, sit through a movie, take a long road trip, or ...

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and death in late-stage studies. Read more at straitstimes.com. Read more at ...

Johnson & Johnson's prostate cancer drug Erleada, reportedly used alongside standard home-blocking therapy before and after ...

Orange County Mayor Jerry Demings recently revealed that he is battling prostate cancer, the second-most common cancer for ...

ASCO's Sunday plenary session will open with results of a 2,109-person global prostate cancer study that showed adding ...